Evidence map›Paper›PMID 42395532›Full record

ArticlebioRxiv : the preprint server for biology2026

Ferroptosis is a Physiologic Vulnerability of Iron-Recycling Macrophages.

Miguel Mesquita, Maria Pires, Sara Violante, Jamil Zola Kitoko, Martim Costa, Sonia Trikha Rastogi, Rui Martins, Silvia Cardoso, Manuel Tanqueiro, Ana Figueiredo and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Miguel MesquitaGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0001-5927-790X
Maria PiresGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.
Sara ViolanteGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0003-2124-5712
Jamil Zola KitokoGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0003-0973-5460
Martim CostaGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.
Sonia Trikha RastogiGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0002-2333-7170
Rui MartinsGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0001-8106-6324
Silvia CardosoGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0003-4639-698X
Manuel TanqueiroGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.
Ana FigueiredoGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0001-9075-2238
Nelli Blank-SteinDevelopmental Biology of the Immune System, Life & Medical Sciences (LIMES) Institute, University of Bonn; 53115 Bonn, Germany.ORCID 0000-0003-2258-736X
Elvira MassDevelopmental Biology of the Immune System, Life & Medical Sciences (LIMES) Institute, University of Bonn; 53115 Bonn, Germany.ORCID 0000-0003-2318-2356
Bindu PaulDepartment of Physiology, Pharmacology & Therapeutics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.ORCID 0000-0002-1862-6103
Moises MalloGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0002-9744-0912
Elisa JenthoGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0002-4790-7860
Miguel P SoaresGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0002-9314-4833

Funding

Thorase Regulation of the Actions of CocaineP50DA044123 · NIDA · JOHNS HOPKINS UNIVERSITY · PI BARABAN, JAY M · 2018 to 2022
$9.0M
Neuroprotective actions of cystathionine g-lyase through gasotransmitter hydrogen sulfide signalingR01AG071512 · NIA · JOHNS HOPKINS UNIVERSITY · PI Bindu Paul · 2022 to 2026
$3.4M
Role of sulfhydration on the functions of the microtubule associated protein, TauR21AG073684 · NIA · JOHNS HOPKINS UNIVERSITY · PI PAUL, BINDU · 2021 to 2022
$450k
NIA NIH HHS R01 AG071512NIA NIH HHS R21 AG073684NIDA NIH HHS P50 DA044123
6 · The paper itself

Abstract

Iron deficiency anemia affects one-third of the global human population. Paradoxically, the daily iron required to fuel the production red blood cell (RBC) and prevent anemia is provided through its recycling from senescent RBC. This is achieved by splenic red pulp macrophages (RPM) that extract iron from the heme groups of hemoglobin (Hb). How these professional erythrophagocytic macrophages prevent intracellular iron flux from inducing cell death via ferroptosis is unknown. Here we show that SPI-C, the master transcriptional regulator of the erythrophagocytic lineage, orchestrates two redundant anti-ferroptosis pathways. One supports glutathione synthesis, via NF-E2-related factor 2 (NRF2), and the other relies on bilirubin production by biliverdin reductase A (BVRA). Genetic ablation of both pathways, but not either alone, sensitizes erythrophagocytic macrophages to ferroptosis, depletes RPM and increases the severity of iron deficiency anemia in mice. These findings reveal a central physiologic role of ferroptosis in the control of macrophage function, iron homeostasis and iron-deficiency anemia.

Identifiers

PMID42395532
PMCPMC13320925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.